Advancing heart failure care: insights from the Heart Failure Policy Summit 2024
The 2024 Heart Failure Policy Summit aimed to share a hopeful outlook on the opportunities that exist to improve heart failure outcomes. So, what did we learn?
European Commission answers tabled questions on heart failure in EU health programmes
Questions from European Heart Failure Mission Policy Champions on the need for specific heart failure funding received responses from the European Commission.
Mental health in heart failure put under the spotlight in new call to action
The HFPN published a new call to action to raise awareness of the relationship between heart failure and mental health, and drive change for this issue at EU level.
New briefing provides heart failure advocates with actionable ways to improve access to best-practice care in Germany
The final advocacy briefing in our From guidelines to action series highlights the opportunities for heart failure advocates to improve care in Germany.
Tackling the overlooked epidemic of heart failure in Germany
Heart failure is prevalent in Germany, but is under-recognised. Key stakeholders came together at the German Heart Failure Roundtable to discuss the need for policy change and comprehensive investment in heart failure care.
It is time to put quality of life at the centre of heart failure care
More than 90% of people with heart failure would like regular discussion about quality of life to be part of their care, but this only happens for 20%.
The Heart Failure Policy Summit will put people with heart failure at the centre of global health policy debates
The Heart Failure Policy Summit will offer an opportunity for heart failure advocates to build alliances across disease areas and link to broader health policy agendas.
How can heart failure advocates in Spain seize current opportunities to improve care?
Our latest policy brief attempts to answer this question, examining existing opportunities and mechanisms to advocate for guideline-recommended care in Spain.
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .
